More Business Wire
View Older Stories View Newer Stories-
SoSafe Introduces The Human Risk OS™, Leading the Category Evolution Towards Human Risk Management
-
State Grid Implements High-Tech Measures for Equipment Safety Inspections
-
E3 Lithium Files First Quarter 2024 Financial Statements and MD&A
-
Enter the Dragon Boat: Hong Kong International Dragon Boat Races Return in June
-
Nidec Announces Annual Dividend Payout from Retained Earnings
-
Nidec Board Authorizes Share Repurchase Plan
-
Nidec Announces the Status of Share Repurchases and the Completion of the Share Repurchase Plan
-
Teleperformance: Combined Shareholders’ Meeting of May 23, 2024
-
Bloom Energy Corporation Prices Upsized $350.0 Million Green Convertible Senior Notes Offering
-
Elliptic Labs Signs Another Expansion License Contract with Top-4 Smartphone Customer Transsion
-
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
-
Scottish Sensor Technology Startup Novosound Targets Expansion in APAC
-
Hibiki Path Advisors Submitted Shareholder Proposals at the 53rd Annual General Meeting of Shareholders of Japan Pure Chemical Co., Ltd. Scheduled for June 25th, 2024
-
Kao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan
-
iStaging reveals Next Generation MR experiences at VivaTech 2024.
-
Mitsubishi Electric to Establish Vietnamese JV for FA Products
-
The World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul
-
Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
-
The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jacks
-
Lee Leads Wire-to-Wire to Win MLF General Tire Heavy Hitters 2024 Presented by Bass Pro Shops on the Kissimmee Chain of Lakes
-
Alibaba Group Prices US$4,500 Million Offering of Convertible Senior Notes
-
Sensedia Launches AI Copilot to Accelerate and Enhance API Development
-
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
-
Limbach Holdings to Participate in Stifel Conference
-
FCPT Announces Sale Leaseback of Eight Mavis Tire Operated Properties for $20 Million
-
Aqua Pennsylvania Files Rate Request Based on Water and Wastewater Operations, Infrastructure Improvements and Repairs Across the Commonwealth
-
Browning West Announces Successful Replacement of Gildan Activewear’s Entire Board of Directors with Full Eight-Member Slate
-
Golden Entertainment Announces Repricing of Term Loan
-
Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala Honors the Los Angeles Chargers and Students Run LA on the 50-yard Line of SoFi Stadium on June 8, 2024
-
Power Integrations to Present at Upcoming Investor Conferences
-
SSR Mining Announces Voting Results From 2024 Annual and Special Meeting of Shareholders
-
Pan American Silver Releases 2023 Sustainability Report
-
Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
-
Pei enters the MSCI COLCAP index
-
Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
-
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
-
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
-
NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
-
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
-
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
-
Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel
-
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
-
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
-
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
-
TelevisaUnivision Announces Pricing of $1.0 Billion Debt
-
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares Distribution
-
KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
-
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
-
Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First

